Menu

Main Library

9 a.m. - 5 p.m.

Phone: (843) 805-6930

West Ashley Library

9 a.m. - 5 p.m.

Phone: (843) 766-6635

Folly Beach Library

Closed for renovations

Phone: (843) 588-2001

John L. Dart Library

9 a.m. - 5 p.m.

Phone: (843) 722-7550

St. Paul's/Hollywood Library

9 a.m. - 5 p.m.

Phone: (843) 889-3300

Mt. Pleasant Library

9 a.m. – 5 p.m.

Phone: (843) 849-6161

Dorchester Road Library

9 a.m. - 5 p.m.

Phone: (843) 552-6466

Edgar Allan Poe/Sullivan's Island Library

9 a.m. - 1 p.m.

Phone: (843) 883-3914

John's Island Library

9 a.m. - 5 p.m.

Phone: (843) 559-1945

McClellanville Library

Closed for renovations

Phone: (843) 887-3699

Edisto Library

9 a.m. - 1 p.m.

Phone: (843) 869-2355

Wando Mount Pleasant Library

9 a.m. - 5 p.m.

Phone: (843) 805-6888

Otranto Road Library

9 a.m. - 5 p.m.

Phone: (843) 572-4094

Hurd/St. Andrews Library

9 a.m. - 5 p.m.

Phone: (843) 766-2546

Baxter-Patrick James Island

9 a.m. - 5 p.m.

Phone: (843) 795-6679

Bees Ferry West Ashley Library

9 a.m. - 5 p.m.

Phone: (843) 805-6892

Village Library

9 a.m. - 1 p.m.

Phone: (843) 884-9741

Keith Summey North Charleston Library

9 a.m. – 5 p.m.

Phone: (843) 744-2489

Mobile Library

Closed

Phone: (843) 805-6909

Item request has been placed!

Item request cannot be made.

Processing Request

Search Results

Display Settings

Results per page: 10

Sort By: Relevance

Your Filters

Subject : clinical medicine Subject : pharmacology Filter by : Subject

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs.

Authors : Coffin, Phillip O.; Santos, Glenn-Milo; Behar, Emily

Subjects: HEPATITIS C treatment; HEPATITIS C; HEPATITIS C virusSAN Francisco (Calif.)

Source: PLoS ONE; 6/3/2019, Vol. 14 Issue 6, p1-13, 13p

Read Online Read More Add to Saved list

Academic Journal

Hepatitis C therapies.

Authors : Melnikova, Irena¹

Subjects: *HEPATITIS C; *HEPATITIS C treatment; *DRUG development

Source: Nature Reviews Drug Discovery. Oct2008, Vol. 7 Issue 10, p799-800. 2p. 1 Black and White Photograph, 2 Charts, 1 Graph.

Read Online Read More Add to Saved list

Academic Journal

Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany.

Authors : Buggisch, Peter; Wursthorn, Karsten; Stoehr, Albrecht

Subjects: HEPATITIS C treatment; HEPATITIS C; HEPATITIS C virusGERMANY; EUROPEEUROPEAN Union

Source: PLoS ONE; 4/4/2019, Vol. 14 Issue 4, p1-10, 10p

Read Online Read More Add to Saved list

Academic Journal

Budgetary impact analysis of a primary care-based hepatitis C treatment program: Effects of 340B Drug Pricing Program.

Authors : Jones, Eric A.; Linas, Benjamin P.; Truong, Ve

Subjects: EPINEPHRINE autoinjectors; DRUG prices; HEPATITIS C treatmentMASSACHUSETTS; BOSTON (Mass.)

Source: PLoS ONE; 3/14/2019, Vol. 14 Issue 3, p1-12, 12p

Read Online Read More Add to Saved list

Academic Journal

Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older.

Authors : Foster, Graham R.; Asselah, Tarik; Kopecky-Bromberg, Sarah

Subjects: HEPATITIS C treatment; THERAPEUTIC use of protease inhibitors; HEALTH of older people

Source: PLoS ONE; 1/2/2019, Vol. 14 Issue 01, p1-13, 13p

Read Online Read More Add to Saved list

Academic Journal

Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?

Authors : Madden, Annie; Hopwood, Max; Neale, Joanne

Subjects: INTERFERONS; HEPATITIS C treatment; DRUG abuse

Source: PLoS ONE; 11/30/2018, Vol. 13 Issue 11, p1-10, 10p

Read Online Read More Add to Saved list

Academic Journal

Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant.

Authors : Perales, Celia; Chen, Qian; Soria, Maria Eugenia

Subjects: HEPATITIS C virus; ANTIVIRAL agents; DRUG resistance

Source: Infection & Drug Resistance; Nov2018, Vol. 11, p2207-2210, 4p

Read More Add to Saved list

Academic Journal

Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infection.

Authors : Venugopal, Vishnu; Padmanabhan, Pranesh; Raja, Rubesh

Subjects: THERAPEUTIC use of interferons; ANTIVIRAL agents; HEPATITIS C treatment

Source: PLoS Computational Biology; 7/12/2018, Vol. 14 Issue 7, p1-26, 26p, 6 Graphs

Read Online Read More Add to Saved list

Academic Journal

Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.

Authors : Vasanthakumar, Aparna; Davis, Justin W.; Abunimeh, Manal

Subjects: GENETIC polymorphisms; RIBAVIRIN; INTERFERONS

Source: PLoS ONE; 5/31/2018, Vol. 13 Issue 6, p1-14, 14p

Read Online Read More Add to Saved list

Academic Journal

New combination antiviral for the treatment of hepatitis C.

Authors : Lam, Jerika T.; Salazar, Laura

Subjects: HEPATITIS C treatment; CARBAMAZEPINE; COMBINATION drug therapy

Source: American Journal of Health-System Pharmacy. 7/15/2016, Vol. 73 Issue 14, p1042-1050. 9p. 2 Charts.

Read Online Read More Add to Saved list